Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)

Market Cap	39.65B
Revenue (ttm)	6.88B
Net Income (ttm)	1.14B
Shares Out	n/a
EPS (ttm)	3.13
PE Ratio	34.92
Forward PE	26.86
Dividend	1.20 (1.58%)
Ex-Dividend Date	Jun 25, 2025

Volume	418,900
Average Volume	317,908
Open	84.00
Previous Close	84.25
Day's Range	82.00 - 86.00
52-Week Range	39.95 - 116.60
Beta	0.31
RSI	62.38
Earnings Date	Mar 31, 2026

About HKG:6821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6821

Financial Performance

In 2024, HKG:6821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial numbers in CNY